Marshall C. Freeman

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program

Sheena K. Aurora, Paul Winner, Marshall C. Freeman et al. · Headache The Journal of Head and Face Pain · 2011 · 291 citations

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

Andrew Blumenfeld, Richard Stark, Marshall C. Freeman et al. · The Journal of Headache and Pain · 2018 · 179 citations · Full text

Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial

David T. Wilkinson, Kristen K. Ade, Lesco L. Rogers et al. · Headache The Journal of Head and Face Pain · 2017 · 53 citations

The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response

Jan Lewis Brandes, Hans‐Christoph Diener, David Doležil et al. · Cephalalgia · 2019 · 37 citations · Full text

Efficacy of Duloxetine as a Migraine Preventive Medication: Possible Predictors of Response in a Retrospective Chart Review

Anne Taylor, James U. Adelman, Marshall C. Freeman · Headache The Journal of Head and Face Pain · 2007 · 35 citations